Picture of IPI Legacy Liquidation Co logo

IMPLQ — IPI Legacy Liquidation Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Impel Pharmaceuticals Announces Exploration Of Strategic Alternatives

Oct 5 (Reuters) - Impel Pharmaceuticals Inc  IMPL.O :
    * IMPEL PHARMACEUTICALS ANNOUNCES EXPLORATION OF STRATEGIC
ALTERNATIVES
    * IMPEL PHARMACEUTICALS INC - INITIATED AN EXPLORATION OF
STRATEGIC ALTERNATIVES
    * IMPEL PHARMACEUTICALS INC - CONTINUES TO PROVIDE FULL
COMMERCIAL
SUPPORT BEHIND TRUDHESA, INCLUDING TRUDHESA DIRECT ACCESS
SUPPORT
    * IMPEL PHARMACEUTICALS INC - CO CURRENTLY EXPECTS TO
CONDUCT THIS
PROCESS OVER REMAINDER OF 2023
    * IMPEL PHARMACEUTICALS INC - GOAL OF CLOSING ANY SUCH
TRANSACTIONS OF PROCESS NO LATER THAN EARLY 2024

Source text for Eikon:  ID:nGNX6yJHLt 
Further company coverage:  IMPL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IPI Legacy Liquidation Co

See all news